Combination of first-line chemotherapy with Kanglaite injections versus first-line chemotherapy alone for advanced non-small-cell lung cancer: study protocol for an investigator-initiated, multicenter, open-label, randomized controlled trial

BACKGROUND: Non-small-cell lung cancer (NSCLC) is usually diagnosed at an advanced stage, and chemotherapy is the main treatment for this disease. Kanglaite injections (KLTi) have been widely used for the treatment of cancer in China. KLTi combined with chemotherapy could improve the short-term effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ruike, Zhang, Ying, Hou, Wei, Li, Jie, Zhu, Guanghui, Zhang, Xiaoxiao, Xu, Bowen, Wu, Zhe, Wang, Heping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966914/
https://www.ncbi.nlm.nih.gov/pubmed/33731199
http://dx.doi.org/10.1186/s13063-021-05169-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966914/
https://www.ncbi.nlm.nih.gov/pubmed/33731199
http://dx.doi.org/10.1186/s13063-021-05169-w

Ejemplares similares